bristoldrv Posted April 12, 2019 Report Share Posted April 12, 2019 Bristol-Myers shareholders greenlight takeover of Celgene AxiosBristol-Myers Squibb received the go-ahead today from more than 75% of shareholders to complete its $74 billion acquisition of Celgene. The big picture: ... View the full article Quote Link to comment Share on other sites More sharing options...